vs
Side-by-side financial comparison of Organon & Co. (OGN) and Rockwell Automation (ROK). Click either name above to swap in a different company.
Rockwell Automation is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× Organon & Co.). Rockwell Automation runs the higher net margin — 14.5% vs -13.6%, a 28.1% gap on every dollar of revenue. On growth, Rockwell Automation posted the faster year-over-year revenue change (11.9% vs -5.3%). Rockwell Automation produced more free cash flow last quarter ($170.0M vs $96.0M). Over the past eight quarters, Rockwell Automation's revenue compounded faster (-0.5% CAGR vs -3.6%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
Rockwell Automation, Inc. is an American provider of industrial automation and digital transformation technologies headquartered in Milwaukee, Wisconsin. Its brands include Allen-Bradley, FactoryTalk software and LifecycleIQ Services. Rockwell Automation employs approximately 27,000 people and has customers in more than 100 countries worldwide.
OGN vs ROK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $2.1B |
| Net Profit | $-205.0M | $305.0M |
| Gross Margin | 49.2% | 48.3% |
| Operating Margin | -9.8% | 20.7% |
| Net Margin | -13.6% | 14.5% |
| Revenue YoY | -5.3% | 11.9% |
| Net Profit YoY | -288.1% | 65.8% |
| EPS (diluted) | $-0.78 | $2.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.6B | $2.3B | ||
| Q2 25 | $1.6B | $2.1B | ||
| Q1 25 | $1.5B | $2.0B | ||
| Q4 24 | $1.6B | $1.9B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.6B | $2.1B | ||
| Q1 24 | $1.6B | $2.1B |
| Q4 25 | $-205.0M | $305.0M | ||
| Q3 25 | $160.0M | $138.0M | ||
| Q2 25 | $145.0M | $295.0M | ||
| Q1 25 | $87.0M | $252.0M | ||
| Q4 24 | $109.0M | $184.0M | ||
| Q3 24 | $359.0M | $239.1M | ||
| Q2 24 | $195.0M | $232.0M | ||
| Q1 24 | $201.0M | $266.2M |
| Q4 25 | 49.2% | 48.3% | ||
| Q3 25 | 53.5% | 69.4% | ||
| Q2 25 | 54.8% | 40.9% | ||
| Q1 25 | 55.6% | 40.5% | ||
| Q4 24 | 56.3% | 38.4% | ||
| Q3 24 | 58.3% | 37.9% | ||
| Q2 24 | 58.4% | 38.8% | ||
| Q1 24 | 59.0% | 39.2% |
| Q4 25 | -9.8% | 20.7% | ||
| Q3 25 | 15.2% | 2.7% | ||
| Q2 25 | 14.4% | 16.0% | ||
| Q1 25 | 6.7% | 14.9% | ||
| Q4 24 | 8.1% | 17.1% | ||
| Q3 24 | 13.1% | 13.5% | ||
| Q2 24 | 14.6% | 12.4% | ||
| Q1 24 | 14.5% | 14.6% |
| Q4 25 | -13.6% | 14.5% | ||
| Q3 25 | 10.0% | 6.0% | ||
| Q2 25 | 9.1% | 13.8% | ||
| Q1 25 | 5.8% | 12.6% | ||
| Q4 24 | 6.8% | 9.8% | ||
| Q3 24 | 22.7% | 11.7% | ||
| Q2 24 | 12.1% | 11.3% | ||
| Q1 24 | 12.4% | 12.5% |
| Q4 25 | $-0.78 | $2.69 | ||
| Q3 25 | $0.61 | $1.24 | ||
| Q2 25 | $0.56 | $2.60 | ||
| Q1 25 | $0.33 | $2.22 | ||
| Q4 24 | $0.42 | $1.61 | ||
| Q3 24 | $1.38 | $2.09 | ||
| Q2 24 | $0.75 | $2.02 | ||
| Q1 24 | $0.78 | $2.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $444.0M |
| Total DebtLower is stronger | $8.6B | — |
| Stockholders' EquityBook value | $752.0M | $3.7B |
| Total Assets | $12.9B | $11.2B |
| Debt / EquityLower = less leverage | 11.49× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $444.0M | ||
| Q3 25 | $672.0M | $468.0M | ||
| Q2 25 | $599.0M | $495.0M | ||
| Q1 25 | $547.0M | $456.0M | ||
| Q4 24 | $675.0M | $477.0M | ||
| Q3 24 | $763.0M | $471.3M | ||
| Q2 24 | $704.0M | $407.0M | ||
| Q1 24 | $575.0M | $470.5M |
| Q4 25 | $8.6B | — | ||
| Q3 25 | $8.8B | $2.6B | ||
| Q2 25 | $8.9B | — | ||
| Q1 25 | $9.0B | — | ||
| Q4 24 | $8.9B | — | ||
| Q3 24 | $8.7B | $2.6B | ||
| Q2 24 | $8.7B | — | ||
| Q1 24 | $8.7B | — |
| Q4 25 | $752.0M | $3.7B | ||
| Q3 25 | $906.0M | $3.7B | ||
| Q2 25 | $733.0M | $3.5B | ||
| Q1 25 | $542.0M | $3.4B | ||
| Q4 24 | $472.0M | $3.4B | ||
| Q3 24 | $493.0M | $3.5B | ||
| Q2 24 | $144.0M | $3.3B | ||
| Q1 24 | $48.0M | $3.5B |
| Q4 25 | $12.9B | $11.2B | ||
| Q3 25 | $13.6B | $11.2B | ||
| Q2 25 | $13.5B | $11.2B | ||
| Q1 25 | $13.2B | $11.0B | ||
| Q4 24 | $13.1B | $10.9B | ||
| Q3 24 | $12.8B | $11.2B | ||
| Q2 24 | $12.2B | $11.2B | ||
| Q1 24 | $11.9B | $11.4B |
| Q4 25 | 11.49× | — | ||
| Q3 25 | 9.74× | 0.72× | ||
| Q2 25 | 12.14× | — | ||
| Q1 25 | 16.52× | — | ||
| Q4 24 | 18.81× | — | ||
| Q3 24 | 17.75× | 0.73× | ||
| Q2 24 | 60.11× | — | ||
| Q1 24 | 181.54× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $234.0M |
| Free Cash FlowOCF − Capex | $96.0M | $170.0M |
| FCF MarginFCF / Revenue | 6.4% | 8.1% |
| Capex IntensityCapex / Revenue | 3.0% | 3.0% |
| Cash ConversionOCF / Net Profit | — | 0.77× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $234.0M | ||
| Q3 25 | $264.0M | $454.0M | ||
| Q2 25 | $220.0M | $527.0M | ||
| Q1 25 | $75.0M | $199.0M | ||
| Q4 24 | $390.0M | $364.0M | ||
| Q3 24 | $141.0M | $432.3M | ||
| Q2 24 | $332.0M | $279.1M | ||
| Q1 24 | $76.0M | $119.8M |
| Q4 25 | $96.0M | $170.0M | ||
| Q3 25 | $218.0M | — | ||
| Q2 25 | $181.0M | $489.0M | ||
| Q1 25 | $43.0M | $171.0M | ||
| Q4 24 | $335.0M | $293.0M | ||
| Q3 24 | $99.0M | — | ||
| Q2 24 | $300.0M | $238.4M | ||
| Q1 24 | $30.0M | $68.6M |
| Q4 25 | 6.4% | 8.1% | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 11.4% | 22.8% | ||
| Q1 25 | 2.8% | 8.5% | ||
| Q4 24 | 21.0% | 15.6% | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 18.7% | 11.6% | ||
| Q1 24 | 1.8% | 3.2% |
| Q4 25 | 3.0% | 3.0% | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.4% | 1.8% | ||
| Q1 25 | 2.1% | 1.4% | ||
| Q4 24 | 3.5% | 3.8% | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.0% | 2.0% | ||
| Q1 24 | 2.8% | 2.4% |
| Q4 25 | — | 0.77× | ||
| Q3 25 | 1.65× | 3.29× | ||
| Q2 25 | 1.52× | 1.79× | ||
| Q1 25 | 0.86× | 0.79× | ||
| Q4 24 | 3.58× | 1.98× | ||
| Q3 24 | 0.39× | 1.81× | ||
| Q2 24 | 1.70× | 1.20× | ||
| Q1 24 | 0.38× | 0.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OGN
Segment breakdown not available.
ROK
| Productsand Solutions | $1.9B | 89% |
| Lifecycle Services Segment | $259.0M | 12% |
